NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Intelligent Bio Solutions Inc. (INBS) announced significant developments in a recent letter to shareholders from President and CEO Harry Simeonidis, reflecting on the company's growth in 2024 and its ...

NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“Intelligent Bio Solutions” or the “Company”), a medical technology company delivering intelligent, rapid, ...

Intelligent Bio Solutions forecasts a 32.6% profit increase, driven by higher-margin cartridge sales and market expansion efforts. Intelligent Bio Solutions Inc. announced preliminary unaudited ...

NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing ...

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Companies to leverage and collaborate on research and development, distribution, and regulatory expertise to accelerate global adoption of intelligent testing technologies Alliance positions INBS to ...

CHICAGO--(BUSINESS WIRE)--CCC Intelligent Solutions Holdings Inc. (CCC) (NASDAQ: CCCS), a leading cloud platform powering the P&C insurance economy, today announced that management will present at the ...

The London Company, an investment management company, released “The London Company SMID Cap Strategy” fourth quarter 2024 ...

Earnings Call Insights: CCC Intelligent Solutions Holdings Inc. (CCCS) Q2 2025 CEO Githesh Ramamurthy reported that "CCC delivered another quarter of strong top and bottom line results, reflecting the ...